← Back to Search

Family Health History Education for Hereditary Diseases in the Black Community (FHH Trial)

N/A
Recruiting
Led By Kent D Key, PhD
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 and older
Be older than 18 years old
Must not have
Younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will create a culturally tailored Family Health History tool to inform and empower African Americans about health risks related to their family genealogy. The goal is to increase preventative behaviors and link people to needed health services to prevent the onset of disease and illness.

Who is the study for?
This trial is for English-speaking African American adults who are interested in learning about their family health history to prevent hereditary diseases and genetic disorders. It's not open to those under 18, non-English speakers, or individuals who do not identify as African American.
What is being tested?
The study is testing a culturally tailored education program designed with input from the African American community. The goal is to increase awareness and use of Family Health Histories for better prevention and linkage to health services.
What are the potential side effects?
Since this intervention involves an educational program rather than a medical treatment, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses when discussing family health histories.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability: Client Satisfaction Questionnaire (CSQ-8-R)
Acceptability: End of Intervention/Treatment Questionnaire
Feasibility: Client Satisfaction Questionnaire (CSQ-8-R)
+4 more
Secondary study objectives
Number of screenings requested
Satisfaction with Family Health History
Understandability
Other study objectives
Health communication
Health literacy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: African American Family Health History Education ProgramExperimental Treatment1 Intervention
The AAFHHEP arm is an intervention to increase utilization of FHH and increase preventative screening. This tool will be culturally tailored by African Americans for African Americans.
Group II: Genetic Alliance: Does it run in the familyActive Control1 Intervention
The Genetic Alliance Does it run in the family is an existing family health history tool kit generalized to all racial groups. This tool is widely available via the internet.

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
198 Previous Clinical Trials
685,655 Total Patients Enrolled
Kent D Key, PhDPrincipal InvestigatorMichigan State University

Media Library

African American Family Health History Education Program Clinical Trial Eligibility Overview. Trial Name: NCT05358964 — N/A
Genetic disorders Research Study Groups: African American Family Health History Education Program, Genetic Alliance: Does it run in the family
Genetic disorders Clinical Trial 2023: African American Family Health History Education Program Highlights & Side Effects. Trial Name: NCT05358964 — N/A
African American Family Health History Education Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05358964 — N/A
~67 spots leftby Jan 2026